Siregar, G., Paramesh, R., Kumawat, R., D, P. and HA, S. (2021) “A prospective, interventional clinical study to evaluate the safety and efficacy of Liv.52 DS in the management of non-alcoholic fatty liver disease”, European Journal of Clinical and Experimental Medicine, 19(2), pp. 129–136. doi: 10.15584/ejcem.2021.2.3.